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Chapter One: INTRODUCTION 
THE PROBLEM 
It is remarkable how wide a variety of chemical agents 
may induce a psychotic state<> A list of some of these not 
only reveals great diversity, but includes members of other*- 
1,2 
wise opposing pharmacological groups: 
depressants: barbiturates, bromides, chloral hydrate; 
stimulants: amphetamine, caffeine; 
autonomic activators and blockers: atropine, scopola¬ 
mine , DFP; 
local anaesthetics: cocaine; 
oxytocics: ergot alkaloids; 
heavy metals: lead, arsenic, mercury; 
hormones:' thyroid, adrenal cortical; 
anti-malarials: atabrine; 
water: excess* 
These substances, mostly drugs in common clinical use, have 
not stimulated the great interest in drug psychoses as has 
the group of so-^call ’’phantasticums" or ’’hallucinogens,” of 
which d-lysergic acid diethylamide (LSD-25) and mescaline 
are the principle members® There are several reasons for 
this® The effects of LSD-25 and mescaline are relatively 
constant and reproducible, whereas with the other agents 
cited there are great differences in sensitivity between 
.individuals, and great variations of response in the same 
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individual from time to time* Moreover, it is felt by some, 
the reactions produced by LSD-25 and mescaline resemble the 
•’functional" psychoses (particularly the group of schizo¬ 
phrenias) more closely than do the reactions, traditionally 
3 A 
labeled "organic,” produced by the other agents., Inde¬ 
pendent of this issue of clinical classification, a reason 
for the great interest in LSD-25? in particular, lies in 
the fact that an extremely minute dose of the drug is high-» 
ly effective in producing a psychotic reaction.. In humans 
less than 10 ' grams per kilogram of body weight can cause 
a marked reaction* In contrast, the dose of mescaline 
customarily used in humans is about 10"3 grams per kilo¬ 
gram*^ This is in a cdLose range of about ten thousand times 
that of LSD-!*25« The fact that an almost molecular quantity 
of a drug, LSD-25? can induce a profound disturbance in 
mental status has in itself revoked interest in a possible 
"organic" etiology in schizophrenia*''' 
Of course, there have been many so-called "organic" 
theories suggested by the fact that drugs can cause a psy¬ 
chotic reaction* The simplest theory is one postulating the 
existence of an endogenous- substance, a "toxin," of which 
the psychosis inducing drugs would be exogenous counter¬ 
parts* Going beyond the level of analogy, one worker has 
o 
even formulated a possible pathway of LSD--25 biosynthesis* 
Another attempt to directly relate the drugs to biological 
systems turns on the structural similarity of mescaline to 
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epinephrine (Fig* 1). It was thought that a metabolic trans¬ 
formation of epinephrine could result in a "mescaline-like1* 
substance, "M" substanceThis led to a study of certain 
oxidative derivatives of epinephrine, and it has been claimed 
some of these substances, for example adrenoxine and adreno- 
chrome (Fig. 1), induce psychotic reactions resembling schizo- 
10 
phrenia even more than do those of LSD-25 and mescaline. 
However, these results have not been consistently repro¬ 
ducible 
What is the current evidence in support of the "toxic" 
theory of etiology in schizophrenia? This comes principally 
from the work of Heath.-*-2 It is claimed that the transfer 
of serum or a certain serum protein fraction, not present 
in normals, ("taraxein") from schizophrenic patients to 
normal subjects can cause a temporary psychotic reaction 
r 
indistinguishable from naturally occuring schizophrenia. 
In a similar kind of experiment Winter reports that serum 
from schizophrenic patients produces a maladaptive behavior¬ 
al change when injected into rats, whereas serum from normal 
humans does not. Of course, the study of biochemical ab- 
lb 
normalities in schizophrenia has a long and complex past. 
One of the more interesting findings in schizophrenic patients 
has been that of low blood glutathione*1''' protein free pineal 
gland extracts, claimed to induce temporary remissions (about 
two weeks) in chronic schizophrenic patients, also correct 
*i ^ 
the blood glutathione abnormality. It is pointed out 
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that tranquillizing drugs do not reverse this abnormality* 
Another biochemical abnormality in schizophrenia is a marked 
1 
increase in urinary phosphate excretion in response to ACTH* 
It is interesting that normal subjects demonstrate this 
same abnormality when given LSD-25* 
However interesting the many findings of biochemical 
peculiarities in schizophrenic patients are in themselves, 
they may simply be secondary changes, and not important to 
the basic disease* The only really direct evidence that bio¬ 
chemical factors play a crucial role in the disease comes 
from the serum transfer experiments cited* The work in this 
area, however, is so recent that there has not been adequate 
confirmation from other laboratories* 
In the foregoing discussion the term "toxic etiology" 
(in schizophrenia) has been used uncritically* Because of 
the controversy between "organic" versus "functional" etio¬ 
logy in this disease, it would be pertinent to consider the 
bearing of work with psychosis inducing drugs and serum from 
schizophrenic patients has on this issue* Supposing it were 
true there was a "toxic" substance in schizophrenic patients, 
would this prove the etiology of schizophrenia was "organic"? 
Or, to place the issue in its most extreme form, suppose 
the elimination or blockade of this "toxin" resulted in a 
remission of the disease* What would such a finding imply 
about the etiology of schizophrenia? One would say that the 
etiology of the disease was organic if the factors leading 
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to the presence of the "toxins'* were principally determined 
by an inherited (or acquired) metabolic defect. On the other 
hand, we know that psychological stresses of various kinds 
can result in chemical alterations in the body. There is 
no reason why certain psychological stresses could not be 
responsible for metabolic disturbances productive of a "tox¬ 
in", which in turn caused the state known as schizophrenia. 
The mere finding of a "toxic" substance in schizophrenic 
patients is quite different from the question of how it ar¬ 
rived there. At our present state of knowledge any "toxin" 
found in schizophrenic patients can only be considered a link 
in the pathogenesis of the disease. It can concievably be 
the result of a purely biochemical process, or it can form 
principally within biochemical conditions established by 
psychological forces. Only when one thinks loosely of a 
"toxin" as being the "etiology" of schizophrenia does the 
identification to the "organic" theory of etiology take place. 
Otherwise, when such a "toxin" is considered as an aspect of 
pathogenesis no definite position about etiology seems man¬ 
datory or justified. Even if a "toxin" were proven beyond 
doubt to exist in schizophrenia, this finding would be inde¬ 
pendent of the traditional controversy over etiology. 
Although it is unlikely schizophrenia has just a 
single determinant, in the preceding discussion this extreme 
case is maintained for arguments sake. Moreover, it is 
improper to speak of "schizophrenia" as such since the group 
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of disorders this terra encompasses not only differ in clin¬ 
ical picture but may have a vide range of contrasting deter¬ 
minants and pathophysiologies.. There may be instances of 
mental illness termed Mschizophrenia1’ that are completely 
determined by hereditary* metabolic factors', other cases 
grouped under the same heading in which psychological fact¬ 
ors dominate the etiological picture “, and further instances 
where there are a multiplicity of etiological factors* There 
are a Variety of things to be determined, as well* Predis¬ 
position, onset, symtomatology, intensity, course, and re¬ 
mission each may have its own particular causal background* 
Finally, in any single schizophrenic patient, at different 
phases in his disease, "organic" or "psychological" factors 
may alternately predominate* 
At any rate there is now at least some evidence that a 
"toxic" factor may play a role in schizophrenia, though not 
necessarily an etiological one* With this possibility in 
mind it can be asked of what value for the understanding of 
mental disease is the study of exogenous substances productive 
of psychotic reactions1? A comparison of clinical syndromes 
in schizophrenia and those found with the drugs might seem 
important to determining the relation between the two* 
Some workers have been particularly impressed by the similarity 
between schizophrenia and LSD-25 or mescaline induced psy- 
choses*^’^^ Others emphasize the differences and therefore 
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tend to see less pertinence to schizophrenia in drug psy- 
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chosis* ? Since in this study the interest will be in 
underlying relationships of a biochemical order it must be 
asked what bearing differences or similarities in clinical 
syndromes have on this basic problem® 
Let it be supposed there was a common biochemical 
system in which both the drugs and the suggested endogenous 
"toxin11 act® It is conceivable this system is a very complex 
one within which there are many sub-systems® Each sub-system 
would be capable of selective response to a variety of 
related agents® Any agent which acted within the broader 
system might affect only a certain pattern of sub-systems, 
and two agents might differ with respect to some aspects of 
the system yet overlap in many others® This biochemical 
postulate can correspond to the pattern of overlap and 
dissimilarity found when comparing symptom pictures of the 
various drugs, and of these to schizophrenia® From this 
point of view differences in clinical picture in the Various 
cases cannot be used as a means of arguing their underlying 
biochemistry may not in large part be identical* On the 
other hand, similarities do not necessitate the latter con¬ 
clusion since there may be more than one pathway leading to 
the same end result* In partial answer to the originally 
posed question as to the relevance of psychosis inducing 
drugs to schizophrenia, it may be said that the similarities 
of drug psychoses to naturally occuring psychoses are 
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interesting on a clinical level, but worthless insofar as 
determining their underlying biochemical relationship® 
Here, an attempt to make deductions from one frame of refer¬ 
ence to another is not valid® 
How can the basic problem of interaction on a bio¬ 
chemical level be approached? No doubt in time it will be 
possible to study such relationships using in vitro enzyme 
systems, and similar techniques® At present however, even 
the grossest correlations in site of action have not been 
established between LSD-25 and mescaline® We are at the 
stage, in this area, of discovering broader relationships, 
such as can be demonstrated by interactions at the in vivo 
level® But how can a biochemical link be revealed in an 
intact subject when there are so many unknown and uncontrolled 
intermediate factors? Two in vivo methods which permit some 
biochemical inferences are those of cross-tolerance and spec¬ 
ific antagonism® These will be the general techniques used 
in this study® 
By specific antagonism id mean antagonism at a 
single receptor (competitive antagonism) or at two very 
closely related receptors® How can antagonists of this type 
be found? In the case of a synthetic drug such as LSD-25 
there is usually available a series of “inert” related com¬ 
pounds ® However , although such a compound may be “inert” 
in the sense that it does not produce the effects of the 
parent drug, it may have receptor “affinity” and thereby 
replace or block the active compound® When an agent is 
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antagonized by its structural homologue there is some assur¬ 
ance that the mechanism of antagonism is competitive (i®e® 
at a single receptor)®"' When there are gross structural 
differences between two active agents such as LSD-25 and mes¬ 
caline, but both have similar effects, the question posed 
as to the relationship of their sites of action can to some 
extent be answered if the inert structural homologue (and 
competitive antagonist) of one also antagonizes the other® 
An example of this situation occurs in the case of Nalorphine 
antagonism of a group of opiates of which it resembles 
closely in structure only one, morphine® Of course, by 
talking about structurel ’’differences'* there is revealed 
an ignorance of a possible structural "essense" in terms 
of receptor affinity® If the competitive antagonist of 
one substance blocked another, superficially different 
substance of similar activity, there would be the strong 
suggestion that such an "essense” did in fact exist® 
Closely related to the concept of antagonism is that 
of cross-tolerance« Here, instead of prevention of effects 
by the actual presence of an antagonist, there a persistent 
alteration at the site of action by an agent no longer present, 
one which exerted its influence at some past time® The cross- 
tolerance found in the case of some narcotics is the most com¬ 
mon example of this phenomenon® If tolerance develops to 
the effects of two agents singly, cross-tolerance between 
the two is suggestive of identical or closely related sites 
of action® If cross-tolerance is not found, however, there 
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is no necessary implication that the sites of action are 
different since it is conceivable each may alter the site 
toward itself but not toward the other. Unidirectional 
cross-tolerance is also possible * Here, one of the agents 
may confer tolerance upon the other, but the reverse would 
not be true» It would be difficult to interpret unusual 
patterns of cross-tolerance, if this were the only informa¬ 
tion availableo However, a combined analysis of cross-tol¬ 
erance results with those of specific antagonism studies 
would provide a firmer basis for drawing conclusions about 
relationships of action site* With the two parameters, 
specific antagonism and cross-tolerance, an intersection of 
patterns may pin-point a biochemical relationship* 
PROGRESS TO DATE 
The problem set forth in the preceding section con¬ 
cerns the relationship between the biochemical sites of 
action of psychosis inducing agents. In this study the 
more specific goal will be toward determining the link, if 
any, between action systems of LSD-25 and mescaline. Of 
the methods that might achieve such an end those of cross- 
tolerance and specific antagonism were emphasized. What 
progress has been made in these and other areas toward 
elucidation of the general problem? 
A theoretical link has been suggested between LSD-25 
and adrenochrome because of the shared indole nucleus 
(Fig. I). Mescaline does not contain an indole nucleus, 
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but since it is speculated mescaline may act through conver¬ 
sion to adrenochrome, or some related indole containing 
compound, the theoretical link is further stretched from 
LSD-25 to mescaline* There is no evidence for this thesiso 
In the area of experimental work there has been some 
evidence presented which at first sight seems to indicate 
LSD-25 and mescaline differ in their mode of action* It 
is claimed each produces, in humans, a somewhat different 
clinical reaction®^ The effects of LSD-25 are claimed to 
be ’’qualitatively" different from those of mescaline* In 
the mescaline reaction "catatonic” features are said to be 
predominant whereas in the LSD-25 reaction a "hebephrenic” 
state is typically found* However, in another study, one 
comparing LSD-25 reactions at various dose levels, it is 
shown that, at higher doses, LSD-25 causes "mental confusion 
21 
and catatonia*" J Since the latter reaction is of the sort 
reported as characteristic of mescaline, the differences in 
clinical picture found between LSD-25 and mescaline in the 
initial study can be accounted for by dosage disparity* 
But even if it is true that, with proper adjustment of dose, 
the clinical syndromes in each case are identical, nothing 
is proved about the relation of their sites of action since 
agents acting through entirely different systems can produce 
the same end result* Here, the inadequacy in a comparison 
of effects for the purpose of linking sites of action par¬ 
allels the previously discussed issue over the meaning of 
differences, in syndrome, between schizophrenia and drug 
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psychoses. 
A more fruitful approach has been in the area of 
tolerance and cross-tolerance,. Isbell first noticed that, 
in non-schizophrenic subjects, repeated administration of 
2b LSD-25 resulted in a rapid diminution of drug effect. 
Even on the second day of a daily dosage schedule there was 
a noticeable degree of tolerance to the effects of the drugo 
That normals develop a state of resistance to the effects 
of LSD-25 is interesting when considered next to the many 
reports that schizophrenic patients have a natural state 
of resistance to the drug, and require higher doses than 
normals for comparable effects.^526,27 jn a (jissenting opin¬ 
ion to this general finding it is felt that schizophrenic 
patients are actually as sensitive to the drug as normals, 
p Q 
but are less able to communicate its effects. If schizo¬ 
phrenic patients are naturally resistant to LSD-25 it would 
suggest the interesting possibility that the hypothetical 
"toxin” in this disease has altered common receptor sites 
such as to make them less sensitive to LSD-25® There is no 
further evidence on this point. 
In species apart from man, tolerance to certain effects 
of LSD-25 has also been reported. Tolerance occurs to the 
pyretogenic effects of LSD-25 in the rabbit.2^ Here, just 
as in man, tolerance is in evidence by the second day. 
There is a mention of tolerance to the behavioral effects 
of LSD-25 in the rat, but no details are given.3° 
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Because tolerance occurs with LSD-25 it would be 
important to know if tolerance also occurred with mescal¬ 
ine. This would open the way for two-way cross-tolerance 
studies. To my knowledge there have been no reports in the 
literature concerning the finding of tolerance to the ef¬ 
fects of mescaline in humans. However, a recent study in¬ 
dicates that dogs become acutely and chronically tolerant 
31 to both the hypotensive and behavioral effects of mescaline.- 
In another study it is shown tolerance does not occur to 
the hypolycemic or bradycardic effects of mescaline in 
the rat. ^ No mention is made of behavioral tolerance in 
this animal. 
Very few cross-tolerance experiments have been reported. 
In a unidirectional cross-tolerance study mescaline was given 
to chronic schizophrenic patients that had been made toler¬ 
ant to effects of LSD-25.-'^ A reaction to mescaline was ob¬ 
tained, This study has two inadequacies. First, it was 
performed in a very small number of chronic schizophrenic 
patients, a group that probably has altered sensitivity to 
LSD-25. Secondly, a proper balance of dose between the two 
drugs, necessary for a conclusive experiment, was not at¬ 
tempted. If the experiment was repeated in normal subjects, 
pretreated with higher doses of LSD-25 or chalanged by a 
lower dose of mescaline, the existence of cross-tolerance 
might be revealed. Of course, if cross-tolerance did not 
occur in man this would not preclude the possibility of its 
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occurrence in other specieso 
It is reported that subjects tolerant to the effects 
of LSD-25 do not respond to 2-bromo-d~lycergic acid diethyl¬ 
amide (BOL-148, Fig* 1)031+ This derivative of LSD-25 does 
not produce the mental effects of the parent drug, except 
at very high levels (in a range of approximately a thousand 
times that of LSD-25)It does produce certain antonomic 
changes at lower doses (e*g* anisocoria), and the unidirect¬ 
ional cross-tolerance demonstrated pertains to such effects* 
Another study indicates that human subjects tolerant to the 
effects of BOL-lVS are likewise tolerant to the effects of 
LSD-25, or at least partially so at the doses of each drug 
used»3^ Thus is established a pattern of two way cross- 
tolerance between LSD-25 and a closely related compound* 
This is of interest from two points of view* First, it shows 
that a relatively benign substance can, in a specific manner, 
protect against a powerful psychosis inducing one* Secondly, 
the fact that BCL-148 confers tolerance to the effects of 
LSD-25 destroys the argument that BOL-148 is inactive because 
it does not cross the "blood-brain barrier," as has been 
suggested* Since BOL-148 alters LSD-25 receptors, as 
evidenced by the existence of cross-tolerance, it must gain 
access to these sites and react with them* But the complex 
or product resulting from the reaction has low "activity", 
in contrast to LSD^25» 
Most of the research in the area of the antagonism of 
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LSD-25 and mescaline has been done with non-specific sup¬ 
pressants* Agents of this type, ameliorating the effects 
of both LSD-25 and mescaline, include sodium amytal, chlor- 
promazineFrenquel,"^ and glutamic and succinic acids*1*0 
It is interesting that all of these substances have some 
activity in suppressing the symtomatology of schizophreniao 
Their effect on LSD-25 and mescaline reactions is probably 
of a non-specific, suppressant nature, although proof of 
this in each case cannot be offered.. Experiments with 
non-specific antagonists can provide little information 
about specific sites of action, and therefore have no value 
in clarifying the general problem in this study* 
As was indicated in the preceding section, one would 
look for specific antagonists among the structural homolo- 
gues of the drug under study* A competitive antagonist 
should have a high "affinity" but low "activity" with res- 
21 pect to the receptor it shares with the active compound* 
From the work with BOL-148, cited above, it can be seen that 
this agent has just such properties, at least in relation to 
the LSD-25 cross-tolerance system, and one might predict it 
would also antagonize, competitively, the parent drug* This 
has been shown the case in several animal species and organ 
systems, though not in a behavioral or psychological one* 
In the mollusk Venus mercenaria heart, BOL-148 will anta- 
4l 
gonize the exitatory effect of LSD-25 on this muscle*" In 
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rabbits, BOL-148, which does not affect blood glucose itself, 
significantly inhibits the hyperglycemic effect of LSD-25* 
The only experiment which to any extent concerns a behavior¬ 
al or psychological system is unfortunately one where the 
factors of cross-tolerance and antagonism are mutually in¬ 
extricable* J BOL-148 was administered to human subjects 
for one and two days before testing with LSD-25 (thus intro¬ 
ducing the factor of cross * tolerance), but BOL-148 was also 
given one to three hours before the LSD-25, in addition to 
the previous daily doses* A complete prevention of LSD-25 
effects was achieved by this means, but since the latter dose 
of BOL-148 was given so close to that of the LSD-25 it is 
impossible to say whether direct antagonism plays any role, 
or the entire result is accounted for by cross-tolerance» 
At any rate, there is a great deal to suggest that BOL-148 
may turn out to be an antagonist of LSD-25 in a behavioral 
system* Beyond these and similar studies with BOL-148 
there.has been no research in the area of specific antagon¬ 
ism of either LSD-25 or mescaline* 
GOALS OF THIS STUDY 
In the preceding section several approaches to the 
general problem of the relationship of the biochemical sys¬ 
tems underlying the action of LSD-25 and mescaline were dis¬ 
cussed* The approach of comparing their respective clinical 
syndromes was considered worthless to this end since even if 
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the effects were identical the drugs could still act through 
separate chemical systems to achieve these effects® The 
work done in the area of cross-tolerance between LSD-25 
and mescaline was considered inconclusive® The other cross¬ 
tolerance work discussed, that of BOL-148 with LSD-25, 
though having no direct bearing on the interrelationship of 
LSD-25 and mescaline, did suggest that BOL-148 can act as a 
competitive antagonist of LSD-25* However, this has not been 
clearly established in a behavioral or psychological system® 
The latter is of importance because, as was pointed out 
earlier in a general way, the finding of an LSD-25 competi¬ 
tive antagonist would allow it to be tested against mescaline 
(or other psychosis inducing agents)® A finding of antagon¬ 
ism to mescaline by such an agent would suggest a close link 
in sites of action between LSD-25 and mescaline® Only a 
specific antagonist can be expected to yield fruitful in¬ 
formation about underlying mechanism® The fact that an agent 
such a chlorpromzaine may suppress the effects of both LSD-25 
and mescaline has little Value in understanding the interrel¬ 
ationship of the two drugs, but if a structural homologue of 
LSD-25 antagonized mescaline the mutuality of antagonist 
in this case would be of great significance® 
The experimental goals in this study follow naturally 
from the foregoing discussion® In the area of cross-toler¬ 
ance a more conclusive experiment is indicated to test the 
possibility of a cross in the direction of LSD-25 to mescaline® 
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Next a cross tolerance study in the reverse direction should 
be performed, preferably in the same experimental subject*. 
It has been pointed out that if a cross occurs in one direct- 
ion it does not necessarily follow the cross is reciprocated®. 
It will also be the goal of this study to elucidate some 
basic properties of the tolerance system itself* 
In the area of specific antagonism the discussion 
first points to the need for establishing whether or not 
B0L-1M3 antagonizes LSD-^25 in a behavioral system* Second¬ 
ly, if such antagonism is found, it must be determined 
whether mescaline is also antagonized by BOL-148* Our ex¬ 
pectation about the result in the latter experiment will 
naturally be influenced by any link between LSD-25 and 
mescaline that might be discovered in the cross^tolerance 
study* 
The fundamental methodological goal will be to find a 
single animal subject in which all the experiments can be 
performed, and a technique which will permit quantitative 
measurement of drug effect in that animal* Later, several 
reasons for the importance of quantitative methods in this 
study will be seen, but it is already of obvious importance 
for cross-tolerance experiments in light of the criticisms 
raised against previous experiments in this field* 
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Chapter Two: EXPERIMENTS 
METHODS 
Introduction: 
Prerequisites to doing the planned cross-tolerance 
and antagonism experiments will be a single animal subject 
showing response to both LSD-25 and mescaline, tolerance to 
behavioral effects of both drugs in this animal, and a suit¬ 
able method for quantitative measurement., 
These prerequisites have already been partially ful¬ 
filled for LSD-25 in the rat» Winter has shown that in rats 
trained to climb a vertical rope, climbing time after LSD-25 
injection varies in a linear fashion according to the log- 
44 dose of drug* The higher the dose the greater the impair¬ 
ment in climbing* The use of this rope climbing method to 
measure drug effects was first used by Macht*^^ I shall 
describe in detail aspects of the method used in the LSD-25 
studyo Once training is complete animals demonstrate ex¬ 
tremely constant control times in trials (3 to 5 seconds)* 
Placebo injections have no effect on climbing time*. In 
contrast, injection of LSD-25 (the lowest dose used: *175 
mg/kgo) causes a rise and fall curve in impairment of per¬ 
formance* Onset of effects is within five minutes, lasting 
twenty minutes or longer, depending on dose* During peak 
drug effects animals often do not climb at all, and an 
electrified grid and a noise emitting loudspeaker at bottom 
of rope is used to force climbing* Even if climbing is 
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thus initiated animals may not complete climb within sixty 
seconds* 
Gross behavioral changes following LSD-25 are corre¬ 
lated with impairment in the climbing test* Gross effects 
consist of an initial few minutes of hyperactivity, after 
which there is a withdrawal to rear of cage* Extremities 
are flexed such that abdomen touches cage floor; a "flat¬ 
tening” effect* While in this position animals may crawl 
around bottom of cage or remain motionless* In contrast to 
normal animals, those treated with LSD-25 do not crowd up to 
cage door in response to experimentorTs approach, but re¬ 
tain the peculiar "flattening” attitude described* It is 
also stated that LSD-25 treated animals placed at bottom of 
rope appear "confused," and once on rope their method of 
climbing differs from normal* Instead of advancing rapidly, 
by parallel use of forepaws and their handpaws, treated rats 
climb slowly, one paw at a time, often stopping and remain¬ 
ing motionless "as though staring into space*" 
In the present study it will be shown that mescaline 
produces an effect in rats measurable by the rope climbing 
test* Gross effects found with this drug are similar to 
LSD-25 effects except that onset is less rapid* It will 
also be shown that tolerance to the effects of mescaline in 
the rat occurs in a fashion similar to its occurrence with 
LSD"?25* 
The prerequisites to doing the cross tolerance and 
antagonism experiments are thus entirely fulfilled by use 
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of the rat as the experimental subject and the rope climbing 
test for quantitative measurement* 
Procedure In This Study; 
Male Sprague-Dawley and Sherman rats weighing from 
175 to 200 grams were used- All fresh animals received an 
initial one week period of taming* This consisted of 24 
hour water deprivation interrupted once each day when ani^ 
mals were allowed to drink five minutes while held in experi- 
mentorrs hands- After this came the training period- Rats, 
kept in individual cages, were fed ten to twelve grams of 
food each day, once a day- Weights were stable for long 
period on this diet* The apparatus allowed rope length to 
be adjusted and training was begun with rope at only twenty 
cm- above floor* Once rats learned to find small reward 
pellet on platform at top of rope they rapidly became pro¬ 
ficient in climbing and length of rope was increased to the 
maximum of 160 cm- After about one week all animals climbed 
to full rope height, and some animals by then had already 
achieved stable trial times- By the end of the second week 
all animals had stable trial times, and during this period 
three placebo injections were given, after three initial 
trials, at 48 hour intervals up to time of use in experi¬ 
ments* On days between experiments fully trained animals are 
not given more than three trials- If trials are carried 
out for long periods (4*5 hours), depending on size of reward 
pellet, animals become satiated, as evidenced by their hoarding 
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of pellets instead of eating. This has no effect on climb¬ 
ing time* Placebos likewise have no effect on climbing 
time. Animals receive three trial runs before an injection 
of drug.o The injection (intraperitoneal) is given either in 
the test situation or in the animal room. A small food 
reward is given at time of injection. Unlike Winter11 s 
procedure electric shock and noise were not used to force 
climbing. Since many of the experiments were chronic ones, 
the use of punishments would introduce an additional factor 
toward development of conditioned fear responses. Treated 
animals not executing climb within one minute of being placed 
in arena at bottom of rope were counted as "failures.” Tim¬ 
ing was performed at 5? 10, 15, 20, (25), 30, and 45 minutes 
after drug injection. Effects, at doses used, were usually 
over by 30 minutes. The standard dose of LSD-25 was .130 
mg/kgo There was little variation in response from animal 
to animal to this dose. On the other hand, there was great 
variability in mescaline response to a dose of 15 mg/kg, 
and this dose was altered up or down to approximate the 
typical effect of .130 mg/kg. Of LSD-25• Climbing time 
was measured from initial leap onto rope to instant nose had 
reached level of platform at top of rope. An electric stop 
clock was used for timing. 
Rope Climbing as a Method: 
Both LSD-25 ana mescaline produce very obvious gross 
effects in rats. In all the experiments to be described 
gross changes corresponded to the presence of high climbing 
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times o The advantage in using the rope climbing test over 
merely observing gross behavioral changes is that the test 
is quantitative and allows differentiation between levels 
of drug effect* Also, the test is sensitive, detecting 
early drug effects before gross changes are apparent* More¬ 
over, the test provides a complex but structured setting 
in which the usual gross behavior can easily be compared to 
abnormal states* The test is, of course, not specific* 
Many agents can cause climbing impairments* 
Although animals will not train unless they are food 
or water deprived, once trained, running time does not de¬ 
pend on hunger drive* When satiated, animals will hoard* 
If fully trained animals are kept from rope for a period of 
months they will, when reintroduced to the climbing test, 
immediately climb almost as well as before* Thus, in trained 
animals, climbing time is relatively independent of both hanger 
drive and further practice* 
Deviant He suits % 
In a small percentage of animals receiving two or more 
closely spaced injections of LSD-25 a "fear" reaction developed 
when animal was again approached for an injection* This 
same thing happened with mescaline, though to a lesser ex-* 
tent* The reaction is manifested by a retreating from the 
experimentor, instead of eagerly entering hand when cage is 
opened* Animals may crouch motionless at such times, and 
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sometimes violently resist handling* When placed in rope 
arena such animals may not climb, and test result will show 
a linear line of "failure" responses instead of the usual 
rise and fall curve characteristic of drug response* For 
the following reasons this "fear" reaction is concluded to 
be a function of drug effects on the animals rather than 
"injection" itself: 
(i) A series of placebo injections tends to prevent 
the reaction from occuring* 
(ii) The reaction occurs to a greater extent with 
LSD-25 than mescaline* The peak effect of the 
former may come on within 5 minutes, whereas 
with the latter, peak effect may not appear 
until 20 minutes after injection* Thus the 
chain from conditioned stimulus (actual in=- 
jection) to unconditioned stimulus (drug 
effect) would shorter for LSD-25* 
(iii) Once a proclivity to respond with a "fear" 
reaction has developed an injection of place¬ 
bo may bring it on just as well as drug, but 
continued placebo injections tend to ex¬ 
tinguish response* 
(iv) LSD-25 injections have no local irritant or 
painful effect* 
The occurence of a "fear" reaction in an animal was 
considered a sufficient criterion for it to be rejected 
from the experimental result* The occasional deviant re¬ 
sults encountered were always on the basis of the "fearn 
reaction* This problem did not arise in the antagonism 
experiments since, here, usually one injection completed 
an experiment* 
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LSD-25• 
MATERIALS 
The structural formula of LSD-25 (d-lysergic acid diethyl¬ 
amide) is shown in figure 1. 
The drug was synthesized in 1943 and. is related struct¬ 
urally to the group of ergot alkaloids (ergometrine type).^ 
It actually has an oxytocic action on the rabbit uterus. 
LSD-25 is not bound or destroyed in the blood, al¬ 
though in tissue homogenates it is rapidly inactivated (with¬ 
in a few minutes).^ 1 In rats, after i.p. injection, the 
highest level of LSD-25 is attained in about 10 to 15 min¬ 
utes. This gradually diminishes within a few hours. Of all 
organs studied, the concentration of LSD-25 reached in the 
brain is the lowest and at all times is lower than in the blood. 
LSD-25 and its metabolites are excreted in the bile. 
Ampuls, 1 ml in size, containing .1 mg of LSD-25, 
prepared by Sandoz Pharmaceuticals Inc., were used in this 
study. 
BOL-148: 
This drug is identical to LSD-25, in structure, ex¬ 
cept for the substitution of one bromine atom for a hydrogen 
atom on the indole nucleus (see Pig. 1). 
Ampuls, 1 ml in size, containing .5 mg of BOL-148, 
prepared by Sandoz Pharmaceuticals Inc,, were used. 
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Mescaline: 
The structure of this drug is shown in figure 1* 
It is the active alkaloid in pcyoce (a crude plant 
derivative)• 
Solutions used (10 ng/ml in concentration) were pre¬ 
pared from mescaline sulfate powder obtained from Bios 
Laboratories Inc* 
RESULTS 
Tolerance To LSD-25s 
Experiment I: Effect of repeated daily injections 
of a constant dose of LSD-25* 
Seven rats were given daily iop«> injections of 0I3O 
mg/kg of LSD-25® On each day of injection drug effects 
were followed by the rope climbing test.. On day one there 
was a marked drug effect (Fig® 2)® On day two animals showed 
somewhat less of a response® On day three there was a 
sharper drop in drug effect than there was from day one to 
day two* Ey the fourth day all rats showed almost complete 
tolerance to the behavioral effects of the drug, measured 
by climbing performance® 
Table One: The group median and the extreme inidividual 
values for day one and day four, in the daily injection 
series, are shown* 
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= Failure to climb within 60 seconds 
TESTING TIMES AFTER i. p. IN J ECT10 N-M I N UTES 
Figure 2, Effect of repeated daily injections of a 
dose of LSD-25 (.130 mg/kg)* 
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Pay Onei Climbing times after i*p* LSD-25 
injection (seconds)* 
Trials ' -> min* 10 min* 15 min* 20 min* 30 min* 45 mil 
Highest animals 3 *6 «=*■«* »■» n» to* 3*2 2,8 
Group median; 3*1 f-y nia 2^.3 14.8 3.6 3.0 
Lowest animal; 2*6 11*0 
f
—1
 
O
 
j*
 3-5 3 -6 2*8 
Day Four: Climbing times ?fter i«p 
injection (second;:)* 
* LSD-25 
Trials 5 min* 10 min* 15 min* 20 min* 30 min * 45 m: 
Highest animal; 3 4*5 5o5 5*0 4*9 4*1 3*: 
Group median: 3-0 3*6 4*5 3*1 2*9 2*8 24 
Lowest animals 2*6 2*6 2*6 3*0 2*8 3.0 2o< 
h_,11 _ Failure to climb within 60 seconds* 
Animals given daily drug injections for four days, but 
not exposed to rope on days two and three, showed the same re¬ 
sult on day four as did the first group* Tolerance can be 
maintained after the fourth day by continued daily injection* 
In tolerant animals effects can again be elicited by larger 
doses* 
Experiment Us Effect of repeated LSD-25 injections 
given at forty-eight hour intervals, at a constant dose level* 
Sis: rats received i*p* injections of *130 mg/kg of 
LSD-25 at forty-eight hour intervals over a period of 13 days* 
This group displayed considerable variability in the develop¬ 
ment of tolerance* One rat failed to acquire an appreciable 
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degree of tolerance during the whole period® Three of the 
animals showed incomplete tolerance at the last injection, 
and two were tolerant at the third injection (Table Two)* 
Table Twos The peak time on each day of LSD-25 injection for 
animals in the forty-eight hour interval group 
is individually recorded* 
Peak Climbing Times (Seconds) 
Days 
Animal 1 a 1 7 9 11 II 
1 23 » 2 21*0 26*7 18*4 — 
2 — 45*8 52.3 32*4 38.8 14«2 26*1 
3 26*9 23*7 19*6 21*4 13.6 17.7 14*1 
4 42*5 38.9 50*1 28*5 18*0 9*0 5*3 
5 14*8 5.5 4*2 4*0 5«3 3 o4 
6 22*4 13.6 6*2 4*7 3*9 4*0 3*7 
H a Failure to climb within 60 seconds •0 
Experiment Ills Effect of repeated LSD-25 injections given 
at seventy- two hour intervals , at a constant dose level* 
The conditions of this experiment were the same as for 
Experiment II except that the interval between doses was 
seventy-twc > hours® Tolerance did not develop in this group * 
Animals were given three trials each on days between inject- 
ions* 
Experiment IVs Effect of an LSD-25 injection given one hour 
after an initial injection of same dose* 
One hour after an initial injection of LSD-25? a second 
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*130 mg#/kg* injection of the drug was given to a group of 
four animalso As can be seen from Figure 3 the second dose 
produced almost no effect® This is in contrast to the rela¬ 
tively large effect at the second injection in Experiment I, 
2b hours after the initial injection (Fig* 2)® 
Experiment Vs Effect of giving *130 mg/kg® of LSD-25 twenty- 
four hours after an initial #260 mg/kg injection# 
Four rats were given #260 mg/kg of LSD-25 on the first 
day of the experiment# On the following day they showed al- 
most no response to #130 mg/kg of LSD-25 (Fig# 4, dash line)* 
Experiment VT: Effect of giving three (constant dose) LSD-25 
injections spaced, after the initial injection, at one hour 
and twenty-four hours# 
In this experiment the same total amount of LSD-25 
was injected on day one as in Experiment V (#260 mg#/kg#,) 
but instead of giving it all at once #130 mg/kg* was given 
initially and *130/kg wasagain given one hour later* 
Figure b (solid line) shows that, in contrast to the result 
in experiment V, a good effect is obtained on day two with 
#130 mg/kg of LSD-25# The effect here is similar in magni¬ 
tude to the effect found if only #130 mg/kg* of LSD-25 is 
given on day one (Fig* 2)* Three animals were used* 
Experiment VII; Decay of LSD-25 tolerance in a daily in¬ 
jection group# 
A group of four animals tolerant to effects of #130 
mg#/kg# of LSD-25) after four daily injections, was allowed 
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x-x= Initial Mescaline injection 
x-x = Initial LSD-25 injection 
x-x - Mescaline I Hour after initial Mescaline 
..x^LS D-25 I Hour after initial LSD-25 
A. = Failure to climb within 60 seconds 
Figure 3. An initial injection of LSD-25 (mescaline) 
followed in one hour by another LSD-25 (mescaline) in¬ 
jection at the same dose level. 
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x--x - 130 8 /Kg. LSD-25at 24 hour time 
(after same dose given at 0 and I hour time 
x———x = 130 if/Kg.LSD-25 at 24 hour time 
(after 2 6 0 8 / Kg. L S D - 2 5 g i ven at 0 time) 
A - Failure to climb within 60 seconds 
Figure L|.  Effect of giving three (constant .130 mg/kg dose) 
LSD-2^T injections spaced after the initial injection, at 
one hour and twenty-four hours. Solid line shows result 
twenty-four hours after initial injection. The dash line 
shows result of a .130 mg/kg LSD-25 injection given twenty 
four hours after an initial .260 mg/kg injection. 
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to go two days without drug injection* On the day after this 
period (the seventh day from the initial injection) there 
was some return in sensitivity to LSD-25 (Table Three)* 
Table Three? The group median for day one and day four of the 
daily injection series is shown with the scores 
of the seventh day (after a gap of two injection¬ 
less days)* 
Median Climbing Times after loP* LSD-25 Injection 
(Seconds) 
Day Trials 5 min* 10 min* 15 min* 20 min* -30 min* 45 min 
1 3*2 10*9 -- 11*0 4,1 3.5 3.2 
4 3*2 3-8 3=6 3*1 3.2 3*0 3 = 1 
7 3«3 6*9 10*4 6*2 3 = 9 3 = 0 3.5 
s Failure to climb within 60 seconds 0 
Tolerance to Mescaline: 
Experiment VIII: Effect of repeated daily injections of a con¬ 
stant dose of mescaline* 
Four rats received daily injections of 10 to-20 mg*/kg 
of mescaline* The dose for each rat was constant* There was 
Variability in this group as to the day tolerance was achieved* 
Two of the animals were found almost completely tolerant on 
the fourth day, one on the fifth, and one on the seventh* 
Continued daily injection maintained tolerance* Table Four 
records the climbing times of the two animals in the group 
showing the overall high and low values on the first day* On 
day four animal B, the one that had shown the greatest response 
on day one, does not demonstrate the almost complete tolerance 
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attained by animal A« Animal B is completely tolerant by 
the seventh day* 
Table Four: Climbing times of the animals having the upper 
and lower extreme scores are shown for day one 
and day four (also day seven for the upper ex¬ 
treme) in the daily mescaline injection series* 
Climbing Times after i*p» Mescaline Injection (Seconds) 
Day Trials 5 min* 10 min* 15 min* 20 min* 30 min* 45 min* 
Animal As Is 3*3 3-7 10*4 15*8 15.9 6.3 
4s 3*4 3-5 3 *6 3*8 3-5 5*4 3*2 
Animal Bs Is 3*2 6*6 — — **»«■■§ 5-2 
4s 3*5 4*7 5*6 10*7 8*2 4*0 
7s 3*1 4*0 2*8 3*3 ' 3-7 3*2 3-5 
ii_„ n s Failure to climb within 60 seconds* 
Experiment IXs Effect of a mescaline injection given one hour 
after an initial injection at same dose* 
Paralleling experiment IV, 10 to 20 mg*/kg* of mescaline 
was given to three rats. One hour later the same dose was 
repeated* At the first injection the animals showed the 
usual marked response, but there was almost no response to 
the same injection one hour later (Fig* 3)• 
Experiment Xs Effect of giving a double dose of mescaline on 
day one, followed by the usual dose twenty-four hours later* 
Paralleling experiment V, three rats were given double 
the usual 10 to 20 mg*/kg of mescaline on day one* On day 
two the dose was dropped to the standard range* There was a 
marked reaction on the first day, but complete tolerance on 
the second day (Table Five)* 
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Table Five? Effects of a double dose on day one, followed by 
the usual dose on day two are shown* 
Median Climbing Times after Mescaline In.iection(Seconds) 
Dose Day Trials 5 min* 10 min*l5min*20min*25min»30min*45mino 
2x(10-20mg/kg) 1 3“^ 6*8 16 *4 ***> -- 11*4 
10-20 mg/kg 2 3*3 4°2 5»2 3*8 3*5 3»8 4*1 3*6 
n—” - Failure to climb within 60 seconds* 
Cross Tolerance 
Experiment XI; Effect of giving mescaline one hour after a 
single dose of LSD-?25 
Figure 5 shows the response of a group of ten rats to 
an initial injection of 10 to 20 mgo/kg* of mescaline* Two 
weeks after the injection this same group was given *130 mgo/kg 
of LSD^25» The response curves in the two cases are roughly 
comparable in duration and intensity (fig* 5? solid lines) 
There is a later time of onset for the mescaline effects* One 
hour after the LSD-25 injection seven rats of this group were 
given the same dose of mescaline that had caused the marked 
effect two weeks earlier (and also did two weeks later)* 
Figure 5 (left side) shows the almost complete prevention of 
mescaline effect in this circumstance* A preliminary chronic 
experiment, with two rats, indicates that animals made toler¬ 
ant to LSD-25 by daily injections are likewise protected 
against effects of mescaline* 
Experiment XII; Effect of giving LSD-25 one hour after a single 
dose of mescaline* 
Of the ten rats used in experiment XI, when tested 
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n 
= In i tial LSD-25 inject ion 
= Me sea line I hour later 
= Initial Mescaline injection 
= LS D-25 I hour later 
3 Failure to climb within 60 seconds 
Figure 5. Graph on left shows effect of giving mescaline 
TTo -20 mg/kg) one hour after a single dose of LSD-25 
(.130 mg/kg). Graph on right shows effect of giving LSD-25 
(,130 mg/kg) one hour after a single dose of mescaline. 
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initially with 10 to 20 mg*/kg» of mescaline (Fig* 5), seven 
were given 0I3O mg*/kg* of LSD-25 after one hour* As is seen 
in Fig* 5 (right side) this group showed a marked response to 
the LSD-25, a response comparable to one produced by LSD-25 
alone* In a chronic experiment, two rats made tolerant to 
the effects of mescaline by daily injections also proved to 
be sensitive to LSD-25« 
Antagonism; 
Experiment XIII* Antagonism of LSD-25 by B0L-148* 
Eight rats were given *130 mg/kg* of LSDi-*25° Their 
response is shown in figure 6* Two weeks later five of these 
were given 1*3 mg*/kg* of B0L-148 in the same injection syringe 
with *130 mg/kg* of LSD*25» From figure 6 it can be seen 
that the usual LSD-25 response is almost completely abolished* 
Three of the original rats were given only *3 mS B0L-148 in¬ 
stead of 1*3 mg*/kg* and the LSD-25 effect is only partly 
abolished (Fig* 6)« In three rats 1*3 mgo/kg* of B0L-148 was 
given five minutes after injection of *130 mg/kg* of LSD-25* 
Figure 6 shows only a partial interruption of the expected 
LSD-25 response* 
E XPER HE NT XIV; Antagonism of mescaline by BOL-148# 
This experiment parallels the preceding. one except 
that mescaline was used in place of LSD-25« Fifteen rats, 
tested with 10 to 20 mg*/kg« of mescaline, showed a marked 
response (Fig* 7)* Two weeks later this same group was given 
1*5 mg*/kg of B0L-148 along with the original dose of mescaline, 
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x —-* = LSD-25 Alone 
*.* = LSD-25 & l.3mg./Kg. B0L-I48 injected together 
LSD-25 a .3m g./Kg.BOL-148 injected together 
x-x = LSD-25 at start, 1.3 m g. /kg. B0L-I48 after 5minutes 
t = Fail ure to climb within 60 seconds 
Figure 60 Antagonismof LSD-25 by BOL-II4.80 Solid line 
sKows response to ,130 mg/kg of LSD-25 alone. Dotted 
line shows result when 1,3 mg/kg of BOL-lIj.8 is injected 
with LSD-25? and dot-dash line shows effect of reducing 
BOL-II4.8 dose to ,3 ^g/kg, Dash line shows effect of a 
1,3 mg/kg injection of BOL-II18 five minutes following an 
LSD-25 injection. 
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x = Mescaline alone 
x — Mescaline 8 l.5mg./Kg.BOL-I48injected together 
x= Mescaline 8 3m g./Kg. BOL-148 i njected together 
x= Mescaline at start, 1.5 mg./Kg. B0L-I48af ter 15 m in. 
= Failure to climb within 60 seconds 
-!-1-1-1-1-1-$-1 
0 5 10 15 20 25 30 45 
TESTING TIMES AFTER i. p. I N J ECT10 N - M I N UT E S 
Figure 7. Antagonism of mescaline by BOL-llj.80 Solid 
Tine shows response to 10 to 20 mg/kg of mescaline 
alone. Dotted line shows result when 1.5 mg/kg of BOL-II4.8 
is injected with LSD-25? and dash line shows effect of 
reducing BOL-I48 dose to .3 mg/kg. Dot-dash line shows 
effect of a 1.5 Tag/kg injection of BOL-II4.8 fifteen min¬ 
utes following a mescaline injection,. 
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in the same injection syringe* As can be seen from the 
figure there was a Virtually complete prevention of mes¬ 
caline effect* When only *3 mg of BOL-148 was used, in 
three animals, only partial protection was achieved* In 
three animals 1*5 mg/kg* of BOL-148 was given fifteen min¬ 
utes after an initial 10 to 20 mg/kg* injection of mescaline 
and the mescaline effect was aborted within five to ten min¬ 
utes (Fig* 7)» 
DISCUSSION OF RESULTS 
The experiments just presented have included aspects 
of tolerance, cross-tolerance, and antagonism* In this 
section the results of each group will be considered separate¬ 
ly* In the final chapter a search for broader theoretical 
relationships will be undertaken* As a preliminary to 
evaluating the tolerance results, the possible role of "learn- 
ingM as the basis for tolerance will be discussed* 
Tolerance and Learning: 
Since the finding cf tolerance (viz* diminishing effect 
with repeated administration) implies nothing about the mech¬ 
anism of the process, even insofar as limiting possibilities 
to the realm of chemical "adaptation," it would be interest¬ 
ing to see if the data presented can at least eliminate the 
possibility that the tolerance found is based on "learning" 
or "adaptation" of the animal to drug effects* It might 
« 
be thought that as tolerance developed the drugs induce the 
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same chemical changes as in the beginning but that the "res¬ 
ponse" to the internal chemical stimulus became altered* More¬ 
over it might be thought that as an animal climbs more and more 
under the influence of the drug, it "learns" to climb despite 
these effects* For the following reasons such a mechanism 
must play a very minimal role in the tolerance process: 
(i) In experiment II, where rats were given LSD-25 
at 48 hour intervals for two weeks, thus re¬ 
ceiving more "experience" with the drug than 
rats in any other group, a significant propor¬ 
tion of the animals developed tolerance slowly 
or not at all* 
(ii) In experiment I, where some rats were given 
LSD-25 injections on days two and three with¬ 
out access to the rope test, the same degree 
of tolerance was attained the fourth day as in 
animals given trials and testing one days two 
and three* 
(iii) Experiment III shows that when drug is omitted 
on days two and three tolerance does not dev¬ 
elop even though trials are given* 
(iv) In experiment XI tolerance to effects of mes¬ 
caline occurs one hour after an initial in¬ 
jection of LSD-25, but the reverse does not 
hold (experiment XII)* If learning was the 
basis of the result in experiment XI then 
one would expect the same result in experiment* 
XII* This is not the case, however* 
This data tends to eliminate the factor of "learning" 
in the tolerance process* Alternative chemical hypotheses 
of mechanism will be discussed in the final chapter* 
Acute and Chronic Tolerance: 
In experiments I and VII (repeated daily injections) 
the gradual development of tolerance to effects LSD-25 and 
mescaline is described* In experiment I, at the second in¬ 
jection, there is only a small decrease in drug effect from 
that of the first day* In contrast to this, experiment IV 
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shows that only one hour after an initial LSD-25 injection 
there is, acutely, almost complete toleranceo Thus, some¬ 
time between one and twenty-four hours after an initial 
injection of LSD-25? there is a considerable decay in tol¬ 
erance* However, in animals made tolerant by daily inject¬ 
ions, tolerance is maintained for at least twenty-four 
hours after each additional injection (experiment I)» Thus, 
from the point of view of decay in tolerance there are at 
least two different tolerance states with LSD-25® If a 
group of animals were presented as an "unknown” and they 
were found tolerant to the effects of LSD-25 in a single test, 
one could not tell if this group would also be completely 
tolerant the following day* If the group happened to be 
tolerant on the basis of chronic drug administration, then 
on the next day the group would still be tolerant, but if it 
was an acute tolerance group there would be a return in sensi¬ 
tivity on the next day (experiment VI)* 
Effect of Time Interval and Dose Levels 
There is a difference in degree of tolerance reached 
after an identical quantity of drug has been given, depending 
on concentration of single doses and on the intervals between 
injections* In the forty-eight hour group tolerance was not 
achieved in some cases even after a comparatively large total 
amount of drug* In this instance each new injection was 
essentially challenging a fresh animal since any tolerance 
that had developed decayed in the long intervals between 
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injections* The variability in the forty-eight hour group is 
probably on the basis of individual Variation in rate of 
decay in tolerance* This situation is in contrast to the 
one in experiment VI where the injection one hour after an 
initial injection has little influence over tolerance at 
twenty-four hours® Here the degree of tolerance attained at 
the third injection compares more with the second than third 
injection of the daily injection series (Figs* 2,4-)* It should 
be noted that the drug, at one hour time, is given during 
the state of acute tolerance (Fig* 3)» The decay in acute 
tolerance is not halted by injection at this time* On the 
other hand tolerance can be maintained by further daily in¬ 
jections when it has resulted from a daily injection series 
(experiment I)» The theoretical implications of these con-' 
trusting facts will be considered in the final chapter* 
Experiment V shows that if, instead of dividing the 
dose of LSD-25 into two injections, given at an hourrs in** 
terval (experiment VI), the total of the two is given at once, 
there is complete tolerance on the second day* Here the same 
total amount of drug gives an entirely different result from 
what is found on day two in experiment VI* The double dose 
may actually be more effective in producing tolerance then 
is the same total amount by daily injection of a constant 
dose in experiment I (Figs* 1, 4)» These results emphasize 
the importance of drug concentration in the production of 
tolerance 
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Cross Tolerance: 
Experiments XI and XII indicate an interesting tut 
complex link between the sites of action of LSD-25 and mes¬ 
caline* Although LSD-25 confers tolerance to mescaline in 
the acute study (and also in the pilot chronic study) there 
is no indication whatsoever that mescaline may diminish 
reactivity to LSD-25® In any cross-tolerance experiment there 
is always the possibility that only with very high doses 
of one agent may a latent cross-tolerance with another agent 
be revealed* But this seems unlikely in face of the fact that 
the tendency seems to actually be toward increased sensitivity 
to LSD-25 after mescaline (Fig. 5)® The possible significance 
of the finding of one way cross-tolerance will be considered 
in the final chapter* 
Antagonism; 
Experiment VIII establishes that BQL-lkS can antagonize 
LSD-25 in a behavioral system* Moreover antagonism is demon¬ 
strated in two different ways* The LSD-25 reaction can be 
prevented by simultaneous injection with B0L-1M3 and the 
reaction can be interrupted by later BOL-?l4-8 injection* 
Similarly, Experiment IX demonstrates the ability of BOL-14-8 
to effectively antagonize mescaline, both by prevention and 
interruption* When a low dose of B0L-lk8 was used, prevent¬ 
ion of both LSD-25 and mescaline effects was not complete* It 
would at first appear from figures 6 and 7 that, at the 1ow 
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dose, BOL-148 antagonized mescaline more effectively than 
it did LSD-25® However, it should he noted the onset of 
mescaline effect is later than that of LSD-25? and the peak 
effects, after injection of mescaline, come at 20 to 30 min¬ 
utes as compared to 5 to 15 minutes for LSD-25® Thus when 
BOL-148 is injected simultaneously with mescaline it has 
more time than with LSD-25 to reach and block receptors® 
Although the dose of antagonist is the same in both cases, 
the effectiveness of antagonism, in terms of dose, is not 
entirely comparable® Nevertheless the effective dose of 
B0L-148 used for both LSD-*25 and mescaline is in approximate¬ 
ly the same range, although the two differ markedly among 
themselves (0I3O mg/kg of LSD-25 as against 10 to 20 mg/kg 
of mescaline)® This kind of relationship between a set of 
agonists and an antagonist (viz® one where the dose of the 
agonists, for a certain effect, Vary widely, but the dose of 
antagonist is the same for each) is considered suggestive 
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of competitive antagonism; antagonism at a single site® 
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Chapter Threes THEORETICAL DISCUSSION 
AND CONCLUSION 
DISCUSSION 
Receptors, An Assumption; 
Thus far the terms "receptor sites" of action, alter¬ 
ation of "receptors," and antagonism at "receptor sites" have 
been used arbitrarily* It is possible for phemonena of 
tolerance and antagonism to be based on processes not re¬ 
lated to "receptor sites" of drug activity.. Since "toler^ 
ance" merely refers to the observed phenomenon of decreasing 
effect with constant dose or increasing dose with constant 
effect, and implies nothing about mechanism, a drug may be¬ 
come decreasingly effective, conforming to the definition of 
tola?ance, because of more rapid detoxification, increased 
rate of excretion, accumulation of an antagonistic substance, 
or finally because of changes in the actual receptor site at 
which the drug acts*. The role of "learning" in tolerance 
has already been discussed* If animals became tolerant to 
effects of LSD-25 or mescaline because of, say, an increased 
rate of excretion, it would be absurd to integrate this re¬ 
sult with those of antagonism experiments where the process 
may be occuring at an entirely different level or site* 
Although all the possible mechanisms of tolerance, 
aside from "receptor" phenomena, cannot at present be ruled 
out, there is, nevertheless, some data which makes several 
of these possibilities Very unlikely* We^haVe studied LSD-25 
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induced bradycardia in rats and find no indication of the 
development of tolerare to this effect, even after twelve 
daily injections. This is long after the appearance of 
tolerance to the behavioral effects of the drug* Similarly, 
chronic experiments with mescaline, induced bradycardia in 
rats have failed to demonstrate toleranceThis data would 
imply, for both LSD-25 and mescaline, that during the stage 
of behavioral tolerance injected drug is present in as high 
a concentration as initially since the effect on heart rate 
is maintained. This tends to rule out the possibilities of 
more rapid detoxification, accumulation of an antagonistic 
substance(at least a circulating one), or increased rate of 
excretion as the basis of tolerance. Although it is by 
no means certain, on the basis of this evidence, that toler¬ 
ance is in fact a specific receptor phenomenon, such an 
assumption has, at least, some support. 
In the case of BOL-148 antagonism of LSD-25 and 
mescaline it can be again asked what assurance there is the 
antagonism occurs at a receptor site. One counter possi¬ 
bility might be the formation of a compound between BOL-148 
and its agonists, resulting in a ‘’peripheral” inactivation. 
However, the fact that BOL-148 confers tolerance to LSD-25-1^ 
tends to show BOL-148 can induce changes in LSD-25 receptors, 
extending to a time when it is no longer present. Here the 
mechanism cannot be the formation of an inter-drug compound 
since only one drug is present at any one time. Thus it is 
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probable BOL-l^S reacts with LSD-25 receptors in the cross¬ 
tolerance experiment, and the further likelihood is that in 
the acute antagonism experiment it also will react with LSD-25 
receptorso 
The Tolerance System: 
In the group of receptors potentially capable of react¬ 
ing with LSD-25 or mescaline, are all alike in their sensi¬ 
tivity to the drugs or are there differences within the 
group? More specifically, are all receptors equally respons¬ 
ive to LSD-25 at any concentration, and therefore is the 
group of receptor reacted with determined purely by chance? 
This question arises from the several puzzling facts brought 
out in the discussion of LSD-25 tolerance re suits* These 
were% 
(i) Acute tolerance is rapidly lost whereas chronic 
tolerance is relatively persistent* There are 
two different tolerance states in terms of de¬ 
cay in tolerance* 
(ii) The standard dose of LSD-^25 may or may not con¬ 
tribute to maintenance of the tolerance state, 
depending on injection interval* LSD-25 given 
during the state of acute tolerance, one hour 
after initial injection, does not prevent the 
decay of tolerance found at twenty-four hours* 
However, daily injections during states of chronic 
tolerance do prevent decay* 
(iii) When twice the standard dose is given initially, 
twenty-four hours later there is almost complete 
tolerance to the standard dose* The totalamount 
of drug, here, is identical to that given in the 
zero, one, and twenty-four hour series, but there 
is renewed sensitivity in the later case* The 
one hour dose makes little difference to toler¬ 
ance * 
A theory will be presented in an attempt to "explain1' 
these contrasting situations* Effects can be obtained in 
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LSD-25 tolerant animals by a dose higher than the one used to 
establish tolerance* The same is true for morphine toler¬ 
ance o Serious toxic effects can be induced in addicts by 
cro Very large doseso It would follow there was a reservoir 
of receptor during certain tolerance states, pregnable only 
by high concentrations of drug® The reaction would not seem 
to follow simple chemical '’mass-action111 law since if only a 
small amount of receptor is inactivated with acquisition 
of tolerance to effects of small doses of LSD-25? there re¬ 
mains a reservoir of receptor that should permit the original 
reaction to proceed, since there is probably little decrease 
in the total amount of receptor* The possible existence of 
a large reservoir during tolerance states is difficult to 
explain if it is assumed all receptors are alike in reactivity* 
It would appear there is a differentiation among re¬ 
ceptors according to the concentration of drug required be¬ 
fore reaction occurs* This may be a property of the receptor 
itself or may be based on its cytological relationships* It 
can be postulated that some receptors will react with low 
concentrations of LSD-25 and others only when high concentra¬ 
tions are present, independent of the total number of receptors* 
Assuming groups of receptor sets, each of limited 
number and each responsive to different levels of drug con¬ 
centration, the question can be asked as to whether these 
sets are independent of one another or whether they are in 
dynamic relation such that members of one set may shift into 
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another set* Could receptors in a high concentration range 
shift into a lower range? Such a postulate of dynamic inter¬ 
change can "explain" the originally stated set of facts as 
follows: 
(i) Acute tolerance may be due to inactivation of the 
susceptible set of receptors* These would be of 
limited number* 
(ii) Rapid recovery from acute tolerance may be ex¬ 
plained as resulting from shift in reservoir re*? 
ceptor to the susceptible range* 
(iii) Slow recovery from chronic tolerance may result 
from a depletion of available reservoir* Recov¬ 
ery now may7 depend upon di novo replacement. 
"Available" reservoir would mean only the re¬ 
ceptor range in close proximity to the susceptible 
one since high doses could still cause an effect, 
(iv) The ineffectiveness of a standard dose of LSD-25 
to contribute to the maintenance of tolerance 
when given during a state of acute tolerance can 
be explained as resulting from the temporary 
insensitivity of that portion of the reservoir 
later contributing to recovery* 
(v) The effectiveness of twice the standard dose 
to confer tolerance to the standard dose at 
twenty-four hours can be the result of an in¬ 
activation of the "higher concentration" portion 
of receptor that has been postulated as respon¬ 
sible for the rapid recovery from acute toler¬ 
ance * 
This proposed theory of receptor dynamics in tolerance 
is just one of many possibilities, and, at our present stage 
of knowledge, has only heuristic value* 
Relationship Between LSD-25 and Mescaline Sites of Action 
The principle facts at hand are, first, that BCL-148, 
a structural homologue of LSD-25, antagonizes the behavioral 
effects of both its parent drug and mescaline. Secondly, 
there is a pattern of unidirectional cross-tolerance, going 
from LSD-25 to mescaline. These facts suggest a close link 
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in sites of action, but they do not necessarily imply the 
sites are identical. 
If it -were assumed LSD-25 and mescaline acted at the 
same site it is easy to see why BOL-148 would antagonize both 
drugs. It is more difficult to understand why there is only 
unidirectional cross-tolerance. It would need to be assumed 
LSD-25 affects the common receptor in such a way as to make 
it insensitive to both mescaline and itself, but that mesca¬ 
line alters the receptor only to itself and not to LSD-25® 
If one made the contrary assumption, namely that LSD-25 
and mescaline act at different sites, now the antagonism of 
mescaline by B0L-1V8 would seem surprising. This is so be¬ 
cause one would wonder why LSD-25 did not react with the 
(different) mescaline receptor if BOL-l^+S could. There is a 
way, however, BOL-148 could antagonize mescaline by means of 
reacting only with the LSD-25 receptor and not with the mes¬ 
caline receptor. One could postulate a chain of receptors 
having directional properties toward an "effects*' system 
such that "distal" receptors must act through more "proximal" 
ones to reach the "effects" system. 
R1-\ R2__-_> R _^ E 
If "R2" were the LSD-25 receptor and "R~" the mescaline 
receptor it is obvious why there would be only unidirectional 
cross-tolerance. Tolerance to mescaline would have no in¬ 
fluence on the ability of "R~" to act at "E" (the "effects" 
p 
system). On the other hand inactivation of "R^", both by 
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means of tolerance to LSD-25 and immediate blocking by BOL-148, 
would prevent approach to ME” by mescaline as well as LSD-25® 
It should be noted that antagonism of mescaline by BOL-148 in 
such a system would constitute a special case of non-competi¬ 
tive antagonism,. 
CONCLUSION 
It was the original goal of this study to determine 
the link, if any, between the sites of action of LSD-25 
and mescaline. Through use of the techniques of cross¬ 
tolerance and specific antagonism certain experimental re¬ 
lationships between the two drugs have been established in 
the rat* BOL-148, a structural homologue of LSD-25? not 
only antagonizes LSD-25 but antagonizes mescaline, a drug 
with no clear structural relation to either BOL-148 or 
LSD-25® The cross-tolerance study displays an interesting 
unidirectional pattern. LSD-25 confers tolerance to mesca¬ 
line, but the reverse is not true. These are findings in a 
single species, and although other species cannot be ex¬ 
pected to behave in an identical fashion, the findings 
probably have a general biological significance. 
The question was raised, in the preceding section, as 
to whether LSD-25 and mescaline act at the same site or at 
very closely related sites. As was seen, it is possible to 
interpret the experimental data according to each of these 
two possibilities. Without additional data it cannot be 
said which one is actually correct. The theoretical frame- 
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work does, however, suggest a way in which the issue can be 
decidedo BOL-148*s antagonism of both LSD-25 and mescaline 
is compatible with the two hypotheses about sites of action* 
It may antagonize mescaline competitively (at a single site) 
or it may antagonize non-competitively (within the chain of 
receptors pictured)* However, a competitive antagonist (and 
structural homologue) of mescaline would not antagonize 
LSD-25 in both circumstances. Such an antagonist would be 
effective against LSD-25 only if mescaline and LSD-25 sites 
were identical. On the other hand, if the sites form an 
integrated chain of receptors, antagonism at ^‘fT'by a mes¬ 
caline homologue would have no influence on LSD-25 activity 
o 1 
since *’R n is later in the chain than **R ”. Thus, depend¬ 
ing on the pattern of antagonism found with a mescaline 
homologue, the single site or the chain theory would be 
favored. A search for antagonists among mescaline homo¬ 
logue s is indicated at this point. 
For certain purposes, however, it is not important 
that definitive knowledge about receptor sites has not been 
achieved. Although BOL-148 establishes a close link between 
LSD^25 and mescaline, the choice of mescaline as a possible 
agonist for BOL-148 was purely arbitrary from the point of 
view of known biochemical relation to LSD-25* In this 
light, the fact that BOL-148 antagonizes mescaline, no 
matter what the precise mechanism may be, should suggest that 
it may antagonize other psychosis inducing drugs as well (e.g, 
bufotenine, adrenochrome or adrenolutin, and JB318). 
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BOL-148 could provide a key to the systematic classification 
of all such substance So Any agent not antagonized by BOL- 
14-8 probably doesn’t act through the mescaline - LSD-25 
receptor system.. 
Since it has been claimed serum from schizophrenic 
patients induces a maladaptive reaction in rats, measurable 
1"5 
by the rope climbint test, J it would be of interest to 
study any influence B0L--148 might have on this reaction0 
Schizophrenic patients themselves are probably resistant to 
BOL-148 since they do show resistance to LSD-25- Thus a 
study of any interaction between BOL-148 and the hypothetical 
Mtoxin" in the serum of schizophrenic patients would be 
better studied in a "neutral" subject where the "toxin" has 
not already caused biochemical change So By use of rats and 
the rope climbing test such a study can be placed oon, the 
quantitative basis important for balancing doses of agon¬ 
ist and antagonisto 
Another factor that can be Varied, in a rat to be given 
serum from schizophrenic patients, is tolerance to the effects 
of Various psychosis inducing agents* This would partly be 
to the end of detecting cross-tolerance« By using combinations 
of cross-tolerance and antagonism, predetermined experimental 
settings of unlimited variation are possibleo For example 
an animal made tolerant by administration of LSD-25 and 
mescaline together would probably present a different bio¬ 
chemical situation from one of separate drug tolerance» By 
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use of these techniques the fundamental problem of the bio¬ 
chemical relation of drug psychoses, if any, to schizophren¬ 
ia can be approached. 
SUMMARY 
Interest in the psychosis inducing agents LSD-25 
and mescaline revolves around the possible relation of 
these to a hypothetical Mtoxin" in schizophrenia. Although 
there are similarities between the drug syndromes and schizo¬ 
phrenia this does not establish the existence of a relation¬ 
ship at biochemical sites. The primary goal in this study 
is to discover the nature of the relationship between the 
biochemical sites of action of LSD-25 and mescaline. This 
knowledge would provide a basis for exploring biochemical 
factors that may contribute to schizophrenia. 
The basic approach to the problem of biochemical re¬ 
lation is through use of the techniques of cross-tolerance 
and specific antagonism.- These are in vivo methods that 
can provide knowledge about relationships in sites of action. 
The experimental subject was the rat. Drug effects were 
measured in a quantitative behavioral test (rope climbing). 
The rat attains tolerance to the behavioral effects of LSD-25 
and it was found tolerance similarly occurs with mescaline. 
Cross-tolerance experiments showed that LSD-25 confers 
tolerance to mescaline, but the reverse does not occur. The 
existence of unidirectional cross-tolerance provides partial 
evidence for some relation In sites of action. 
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In antagonism studies it was found that BOL-148, 
an "inert” derivative of LSD-25? antagonizes the parent drug* 
Since this structural homologue probably antagonizes LSD-25 
at its biochemical site of action, antagonism of other psy¬ 
chosis inducing agents would provide information about the 
relation of their sites of action to those of LSD-25* It 
was found BOL-148 is an effective antagonist of mescaline, 
a drug with no known structural or experimental relation to 
LSD-25* 
It is concluded the cross-tolerance and antagonism 
experiments indicate a very close relation between the bio¬ 
chemical sites of action of LSD-25 and mescaline, but that 
the sites may not actually be identical. 
The choice of mescaline as the agent to be tested 
against BOL-148 was purely arbitrary insofar as known bio¬ 
chemical relation to LSD-25* In this light it might be ex¬ 
pected BOL-148 would antagonize other psychosis inducing 
agents, and thus provide a means for systematic classifica¬ 
tion of all such substances. Any agent not antagonized by 
BOL-148 probably does not at the mescaline-Lsd-25 sites. 
Furthermore, since serum from schizophrenic patients induces 
effects in rats similar to those of LSD-25 and mescaline, 
antagonism of such effects by BOL-148 would indicate a bio¬ 
chemical relation between the psychosis inducing drugs and 
the hypothetical"toxin" of schizophrenia. The latter study 
can be supplemented by use of cross-tolerance techniques. 
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The properties of the tolerance system itself are 
also discussed in terms of several experimental results® 
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